Sioux Falls, S.D.-based Sanford Health has become the first health system in the U.S. to integrate a new intelligent automation technology in its molecular laboratory.
The system, known as Molecular Process Optimization, was developed by Roche Diagnostics. It combines new instrumentation with software designed to streamline molecular testing, reduce turnaround times and improve cost-effectiveness.
According to a May 28 news release from Sanford Health, the technology allows for expanded testing capabilities and better support for clinical decision-making — particularly in time-sensitive situations.
The system is expected to benefit high-need populations, such as transplant patients, by enabling faster and more comprehensive diagnostics. Sanford Health said the technology will also support efforts to make specialized testing more widely accessible.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
